Why involve IRBs now?

At this stage, the protocol and supporting documents are prepared for formal IRB review, and study teams begin coordinating with investigators and sites to support study startup.

Aligning materials with IRB expectations and ensuring readiness for submission helps reduce delays and supports a smooth transition from approval to study activation.

Helpful actions at this stage:

• Submit the final protocol package and all required materials to the IRB
• Respond promptly to IRB questions and requested revisions
• Ensure the informed consent form is clear, accurate, and written in plain language
• Finalize safety monitoring and adverse event reporting plans
• Maintain complete documentation of all submissions and communications

Site and Investigator Readiness

• Distribute the final protocol and conduct study kickoff meetings
• Train sites on procedures, safety reporting, and required systems
• Clearly communicate expectations (e.g., timelines, data entry, recruitment)
• Share protocol updates and amendments through timely communication

IRB approval marks the transition to study implementation, with ongoing responsibilities for amendments, safety reporting, and continuing review.

What aspects of the protocol should IRBs evaluate?

• Study design and scientific justification
• Informed consent materials
• Risk–benefit framework
• Participant selection and protections
• Data privacy and confidentiality
• Safety monitoring plans
• Regulatory and ethical compliance